Saturn V Capital Management Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Saturn V Capital Management Lp disclosed 23 stock positions valued at approximately $697.47M as of quarter-end June 30, 2026. The largest holdings include AMYLYX PHARMACEUTICALS INC, ALUMIS INC, and ABIVAX SA.
- Report Period
- June 30, 2026
- No. of Stocks
- 23
- Portfolio Value
- $697.47M
Holdings by Sector
Saturn V Capital Management Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 11.91% | 4,624,101 | +274,216 | +6.30% | $83,048,854 |
| ALUMIS INC | ALMS | Healthcare | 11.76% | 2,915,443 | -286,632 | -8.95% | $82,040,566 |
| ABIVAX SA | ABVX | Healthcare | 9.91% | 518,865 | -23,831 | -4.39% | $69,143,950 |
| VAXCYTE INC | PCVX | Healthcare | 7.11% | 852,914 | +28,382 | +3.44% | $49,579,891 |
| IMMIX BIOPHARMA INC | IMMX | Healthcare | 6.89% | 4,658,429 | +964,844 | +26.12% | $48,028,403 |
| PHARVARIS N V | PHVS | Other | 6.52% | 1,314,122 | +112,720 | +9.38% | $45,442,339 |
| JAZZ PHARMACEUTICALS PLC | JAZZ | Other | 5.56% | 160,938 | -2,023 | -1.24% | $38,781,230 |
| CELCUITY INC | CELC | Healthcare | 5.55% | 370,318 | +88,414 | +31.36% | $38,742,669 |
| DISC MEDICINE INC | IRON | Healthcare | 5.50% | 524,730 | +74,804 | +16.63% | $38,378,752 |
| CANDEL THERAPEUTICS INC | CADL | Healthcare | 4.88% | 3,303,686 | +407,098 | +14.05% | $34,027,966 |
| X4 PHARMACEUTICALS INC | XFOR | Other | 4.67% | 6,973,343 | +516,697 | +8.00% | $32,565,512 |
| MONOPAR THERAPEUTICS INC | MNPR | Other | 4.14% | 311,976 | -33,650 | -9.74% | $28,885,858 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 3.37% | 1,057,493 | +90,884 | +9.40% | $23,486,920 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 2.81% | 1,052,043 | +1,052,043 | +100.00% | $19,620,602 |
| ZURA BIO LTD | ZURA | Other | 1.78% | 2,101,119 | +1,361,159 | +183.95% | $12,396,602 |
| SAGIMET BIOSCIENCES INC | SGMT | Healthcare | 1.64% | 1,479,918 | +1,479,918 | +100.00% | $11,439,766 |
| OCULIS HOLDING AG | OCS | Healthcare | 1.36% | 684,880 | +168,119 | +32.53% | $9,499,286 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 1.13% | 3,869,056 | +5,611 | +0.15% | $7,854,184 |
| VIR BIOTECHNOLOGY INC | VIR | Healthcare | 1.13% | 770,643 | +770,643 | +100.00% | $7,852,852 |
| INVIVYD INC | IVVD | Healthcare | 1.05% | 8,392,288 | -2,556,796 | -23.35% | $7,321,432 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 0.69% | 182,829 | +93,830 | +105.43% | $4,824,857 |
| SATELLOS BIOSCIENCE INC | MSLE | Other | 0.39% | 350,000 | - | - | $2,721,250 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 0.26% | 663,060 | -3,503,606 | -84.09% | $1,783,631 |
Showing 23 of 23 holdings in the latest reporting period.